Role of NOD1 and ALPK1/TIFA Signalling in Innate Immunity Against Helicobacter pylori Infection
- PMID: 31123889
- DOI: 10.1007/978-3-030-15138-6_7
Role of NOD1 and ALPK1/TIFA Signalling in Innate Immunity Against Helicobacter pylori Infection
Abstract
The human pathogen Helicobacter pylori interacts intimately with gastric epithelial cells to induce inflammatory responses that are a hallmark of the infection. This inflammation is a critical precursor to the development of peptic ulcer disease and gastric cancer. A major driver of this inflammation is a type IV secretion system (T4SS) encoded by the cag pathogenicity island (cagPAI), present in a subpopulation of more virulent H. pylori strains. The cagPAI T4SS specifically activates signalling pathways in gastric epithelial cells that converge on the transcription factor, nuclear factor-κB (NF-κB), which in turn upregulates key immune and inflammatory genes, resulting in various host responses. It is now clear that H. pylori possesses several mechanisms to activate NF-κB in gastric epithelial cells and, moreover, that multiple signalling pathways are involved in these responses. Two of the dominant signalling pathways implicated in NF-κB-dependent responses in epithelial cells are nucleotide-binding oligomerisation domain 1 (NOD1) and a newly described pathway involving alpha-kinase 1 (ALPK1) and tumour necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein with forkhead-associated domain (TIFA). Although the relative roles of these two pathways in regulating NF-κB-dependent responses still need to be clearly defined, it is likely that they work cooperatively and non-redundantly. This chapter will give an overview of the various mechanisms and pathways involved in H. pylori induction of NF-κB-dependent responses in gastric epithelial cells, including a 'state-of-the-art' review on the respective roles of NOD1 and ALPK1/TIFA pathways in these responses.
Keywords: ALPK1; NOD1; Peptidoglycan; TIFA; cagPAI.
Similar articles
-
TIFA Signaling in Gastric Epithelial Cells Initiates the cag Type 4 Secretion System-Dependent Innate Immune Response to Helicobacter pylori Infection.mBio. 2017 Aug 15;8(4):e01168-17. doi: 10.1128/mBio.01168-17. mBio. 2017. PMID: 28811347 Free PMC article.
-
ALPK1- and TIFA-Dependent Innate Immune Response Triggered by the Helicobacter pylori Type IV Secretion System.Cell Rep. 2017 Sep 5;20(10):2384-2395. doi: 10.1016/j.celrep.2017.08.039. Cell Rep. 2017. PMID: 28877472
-
TIFA has dual functions in Helicobacter pylori-induced classical and alternative NF-κB pathways.EMBO Rep. 2021 Sep 6;22(9):e52878. doi: 10.15252/embr.202152878. Epub 2021 Jul 30. EMBO Rep. 2021. PMID: 34328245 Free PMC article.
-
Nucleotide-binding oligomerization domain 1 and Helicobacter pylori infection: A review.World J Gastroenterol. 2018 Apr 28;24(16):1725-1733. doi: 10.3748/wjg.v24.i16.1725. World J Gastroenterol. 2018. PMID: 29713127 Free PMC article. Review.
-
Nucleotide-binding oligomerization domain 1 and gastrointestinal disorders.Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(8):578-599. doi: 10.2183/pjab.93.037. Proc Jpn Acad Ser B Phys Biol Sci. 2017. PMID: 29021509 Free PMC article. Review.
Cited by
-
The Protective Effects of Helicobacter pylori Infection on Allergic Asthma.Int Arch Allergy Immunol. 2021;182(1):53-64. doi: 10.1159/000508330. Epub 2020 Oct 20. Int Arch Allergy Immunol. 2021. PMID: 33080611 Free PMC article. Review.
-
Helicobacter pylori promotes gastric cancer through CagA-mediated mitochondrial cholesterol accumulation by targeting CYP11A1 redistribution.Int J Biol Sci. 2024 Jul 15;20(10):4007-4028. doi: 10.7150/ijbs.96425. eCollection 2024. Int J Biol Sci. 2024. PMID: 39113698 Free PMC article.
-
Gastrointestinal epithelial innate immunity-regionalization and organoids as new model.J Mol Med (Berl). 2021 Apr;99(4):517-530. doi: 10.1007/s00109-021-02043-9. Epub 2021 Feb 4. J Mol Med (Berl). 2021. PMID: 33538854 Free PMC article. Review.
-
Isolation and characterization of Helicobacter suis from human stomach.Proc Natl Acad Sci U S A. 2021 Mar 30;118(13):e2026337118. doi: 10.1073/pnas.2026337118. Proc Natl Acad Sci U S A. 2021. PMID: 33753513 Free PMC article.
-
Biomaterials for Helicobacter pylori therapy: therapeutic potential and future perspectives.Gut Microbes. 2022 Jan-Dec;14(1):2120747. doi: 10.1080/19490976.2022.2120747. Gut Microbes. 2022. PMID: 36070564 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical